Severe Asthma 2018: Advances in Pathogenesis and Treatment

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Severe Asthma 2018: Advances in Pathogenesis and Treatment

Videos
Events

Playback speed

10 seconds

TYRO3 Receptor Tyrosine Kinase is a Negative Regulator of Type 2 Immunity

By Severe Asthma 2018: Advances in Pathogenesis and Treatment FEATURING Carla Rothlin

144 views

October 30, 2018

Comments 0

Shifting to Inhaled Corticosteroid-Containing Rescue Therapy in 2024

Feat. N. Skolnik, W. Wright

Videos

Asthma Management Overview

Severe Asthma 2018: Advances in Pathogenesis and Treatment

L. Cohn

847 views

Breaking Barriers: Mechanisms and Consequences of Epithelial Barrier…

Severe Asthma 2018: Advances in Pathogenesis and Treatment

S. Georas

283 views

In Vivo Models of Epithelial Barrier Function

Severe Asthma 2018: Advances in Pathogenesis and Treatment

S. Georas

116 views

TYRO3 Receptor Tyrosine Kinase is a Negative Regulator of Type 2 Imm…

Severe Asthma 2018: Advances in Pathogenesis and Treatment

C. Rothlin

144 views

Parsing the Heterogeneity of Immune Responses in Severe Asthma

Severe Asthma 2018: Advances in Pathogenesis and Treatment

A. Ray

214 views

Next Generation Therapy in Severe Asthma: Identifying Targets to Sup…

Severe Asthma 2018: Advances in Pathogenesis and Treatment

A. Ray

320 views

Leveraging Epigenetic Data to Understand the Asthma Trajectory

Severe Asthma 2018: Advances in Pathogenesis and Treatment

D. Vercelli

136 views

From Mom to Baby: Epigenetics and the Trajectory to Childhood Asthma

Severe Asthma 2018: Advances in Pathogenesis and Treatment

D. Vercelli

510 views

Spontaneous Protein Crystallization as a Novel Therapeutic Target in…

Severe Asthma 2018: Advances in Pathogenesis and Treatment

B. Lambrecht

323 views

Next Generation Biologics for Severe Asthma: Targeting the Chitinase…

Severe Asthma 2018: Advances in Pathogenesis and Treatment

G. Chupp

426 views

Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Se…

Severe Asthma 2018: Advances in Pathogenesis and Treatment

G. Chupp

311 views

Severe Asthma Subgroups with High YKL-40

Severe Asthma 2018: Advances in Pathogenesis and Treatment

J. Gomez-Villalobos

226 views

Asthma-COPD Overlap: Myth or Reality?

Severe Asthma 2018: Advances in Pathogenesis and Treatment

B. Celli

1.1K views

Asthma-COPD Overlap: Why is this Overlap a Problem?

Severe Asthma 2018: Advances in Pathogenesis and Treatment

B. Celli

3.5K views

Immunotherapy for Food Allergy: Key Concepts

Severe Asthma 2018: Advances in Pathogenesis and Treatment

J. Wang

539 views

Oral Immunotherapy (OIT) for Food Allergy

Severe Asthma 2018: Advances in Pathogenesis and Treatment

J. Wang

504 views

Sublingual and Epicutaneous Immunotherapy for Food Allergy

Severe Asthma 2018: Advances in Pathogenesis and Treatment

J. Wang

157 views

Use of Biologics in Severe Food Allergies

Severe Asthma 2018: Advances in Pathogenesis and Treatment

J. Wang

152 views

Severe Asthma: Advances in Pathogenesis and Treatment Discussion

Severe Asthma 2018: Advances in Pathogenesis and Treatment

L. Cohn

205 views